Immunohistochemistry Neuroendocrine Tumor Panel in UAE | 1000 AED | 2026 DHA Guidelines

تحليل لوحة الأورام العصبية الصماوية بالكيمياء النسيجية المناعية في الإمارات | 1000 درهم | معتمد من هيئة الصحة بدبي

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Legal Compliance: This service strictly complies with Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL data privacy standards.

Overview

The Immunohistochemistry Neuroendocrine Tumor Panel is a specialized pathology test that uses IHC markers to characterize neuroendocrine neoplasms with high diagnostic precision. (هذا الاختبار الشامل يستخدم الكيمياء النسيجية المناعية لتحديد أنماط الأورام العصبية الصماوية بدقة تشخيصية عالية)

Feature	Our Test (IHC Panel)	Closest Alternative
Precision	Multi-marker IHC with automated quantification & digital pathology	Single antibody testing, subjective scoring
Methodology	ISO 9001:2015 accredited IHC on FFPE tissue, full digital reporting	Standard manual IHC, limited QC
Turnaround Time	5–7 days for complex cases; rapid processing	7–14 days, variable

Physician Insight & Safety Protocol

Dr. PRABHAKAR REDDY (DHA: 61713011) emphasizes: “Every neuroendocrine tumor is biologically unique; IHC panels must be interpreted alongside full clinical context, imaging, and histopathology. No single marker defines aggressiveness. This test provides a comprehensive immunophenotypic map to guide precision therapy, but clinical correlation is imperative.”

⚠️ Important Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Some medications may affect tumor marker expression; always inform your physician about all current treatments before biopsy.

Exclusion Criteria & Emergency Red Flags

Patients with severe coagulopathy or bleeding diathesis require pre-procedural clearance.
Tissue samples must be adequate; necrotic or extensively crushed biopsies may yield inconclusive results.
In case of sudden severe pain, hemodynamic instability, or signs of carcinoid crisis post-biopsy, seek emergency medical attention immediately.

Patient FAQ & Clinical Guidance

Q: What exactly does the Immunohistochemistry Neuroendocrine Tumor Panel measure?

This panel utilizes a panel of antibodies against neuroendocrine differentiation markers (such as chromogranin A, synaptophysin, CD56, Ki-67, and specific hormonal markers) to determine tumor origin, grade, and potential therapeutic targets from a tissue biopsy.

س: كيف يساعد تحليل لوحة الأورام العصبية الصماوية بالكيمياء النسيجية المناعية في توجيه العلاج؟

يوفر هذا الفحص خريطة مناعية دقيقة للورم تشمل مؤشرات الانقسام (Ki-67) وعلامات التمايز العصبي الصماوي، مما يسمح بتصنيف الورم وتحديد العلاجات المستهدفة المناسبة وفق البروتوكولات الحديثة.

Q: How fresh does the tissue sample need to be, and can I use a previously stored block?

Formalin-fixed paraffin-embedded (FFPE) blocks are ideal; we accept previously stored blocks as long as fixation was adequate. Submit tissue in 10% formal-saline at room temperature with a copy of the histopathology report, biopsy site, and clinical history.

س: ما هي المدة الزمنية المتوقعة لصدور التقرير بعد أخذ العينة؟

تصدر التقارير في غضون 5 أيام للخزعات البسيطة، و7 أيام للعينات المعقدة، وفق معايير الجودة المعتمدة من هيئة الصحة بدبي.

Q: Does insurance cover this, and how can I verify?

We offer direct billing assistance; contact our support team via WhatsApp at +971 54 548 8731 with your insurance details for pre-approval verification. Most major UAE insurers cover this essential diagnostic panel.

دعم ثنائي اللغة متاح